{"id":"NCT01782326","sponsor":"Novartis Pharmaceuticals","briefTitle":"QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations)","officialTitle":"A 52-week Treatment, Multi-center, Randomized, Double-blind, Double Dummy, Parallel-group, Active Controlled Study to Compare the Effect of QVA149 (Indacaterol Maleate / Glycopyrronium Bromide) With Salmeterol/Fluticasone on the Rate of Exacerbations in Subjects With Moderate to Very Severe COPD. (FLAME).","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2015-09","completion":"2015-09","firstPosted":"2013-02-01","resultsPosted":"2016-05-16","lastUpdate":"2016-05-16"},"enrollment":3362,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":[]},{"type":"DRUG","name":"Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)","otherNames":[]}],"arms":[{"label":"QVA149","type":"EXPERIMENTAL"},{"label":"Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the efficacy, safety and tolerability of QVA149 in patients with moderate to very severe COPD.","primaryOutcome":{"measure":"Rate of COPD Exacerbations","timeFrame":"52 weeks","effectByArm":[{"arm":"QVA149","deltaMin":3.59,"sd":null},{"arm":"Long Acting B2 Agonist (LABA) and Inhaled Corticosteroid (ICS)","deltaMin":4.03,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":"0.003"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":33},"locations":{"siteCount":499,"countries":["Argentina","Austria","Belgium","Bulgaria","Canada","Chile","China","Colombia","Croatia","Czechia","Denmark","Estonia","Finland","France","Germany","Greece","Guatemala","Hong Kong","Hungary","Iceland","India","Italy","Japan","Latvia","Lithuania","Mexico","Netherlands","Norway","Philippines","Poland","Portugal","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Sweden","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["38992490","32321518","30621717","30019939","29925383","28278391","27181606"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":308,"n":1678},"commonTop":["CHRONIC OBSTRUCTIVE PULMONARY DISEASE","NASOPHARYNGITIS","UPPER RESPIRATORY TRACT INFECTION BACTERIAL","VIRAL UPPER RESPIRATORY TRACT INFECTION","LOWER RESPIRATORY TRACT INFECTION"]}}